The Association between Fever and Prognosis in Lung Cancer Patients with Bone Metastases Receiving Zoledronic Acid
2017
Zoledronic acid is an established agent used in the management of metastatic bone disease. The administration of zoledronic acid improves overall survival (OS) of lung cancer patients with bone metast
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
30
References
4
Citations
NaN
KQI